A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response (MENTOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01523340
Recruitment Status : Unknown
Verified January 2013 by Young-Chul Kim, Chonnam National University Hospital.
Recruitment status was:  Recruiting
First Posted : February 1, 2012
Last Update Posted : January 31, 2013
Roche Pharma AG
Information provided by (Responsible Party):
Young-Chul Kim, Chonnam National University Hospital

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2014
  Estimated Study Completion Date : December 2015